^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Multiple Myeloma |
| Drug: | Xpovio (selinexor) (XPO1 inhibitor) + pomalidomide (TNFα inhibitor, IL-6 inhibitor, NK cell stimulant, IL-10 stimulant, IL-1β inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
04/12/2021
Excerpt:
Therapy for previously treated Multiple Myeloma…Other recommended regimens…selinexor/pomalidomide/dexamethasone
Secondary therapy:
dexamethasone
